GlassScriptPhysician profile
Muhammad Mujahid Salim
NPI 1760467419
$10,661.26
in general payments reported to CMS, 2019-2025
28 companies · $494 in 2025
The $494 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $72.09 · 2022: $3,957 · 2023: $6,047 · 2024: $90.92 · 2025: $494.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,011 · Food and Beverage: $459 · Travel and Lodging: $163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,010.53 |
| Food and Beverage | $458.87 |
| Travel and Lodging | $163.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,956.56 | 2022-2023 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $286.30 | 2024-2025 | Saphnelo, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $97.88 | 2023-2025 | Nucala, Trelegy Ellipta, Shingrix |
| Mylan Specialty L.P. | $56.04 | 2024 | Yupelri |
| Viatris Specialty LLC | $52.09 | 2025 | Yupelri |
| Verona Pharma, INC. | $48.43 | 2025 | Ohtuvayre |
| Genentech USA, INC. | $39.95 | 2019 | |
| Gilead Sciences, INC. | $26.53 | 2023 | Veklury |
| Mallinckrodt Hospital Products INC. | $25.11 | 2025 | Acthar |
| Harmony Biosciences LLC | $20.17 | 2024 | |
| Lilly USA, LLC | $20.06 | 2025 | Zepbound |
| Philips North America LLC | $19.44 | 2019 | |
| Merck Sharp & Dohme LLC | $12.70 | 2019 |
15 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Salim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.